了解边缘性卵巢瘤的分子机制的进展

Shiying Chen1, Li Huang1, Meili Liang1

  • 1Department of Gynecology and Obstetrics, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, Fujian, China.

PubMed
概括

这项研究回顾了最近在诊断边缘性卵巢瘤 (BOT) 的进展. 它侧重于分子机制和生物标志物,以改善早期检测和治疗策略,以获得更好的患者结果.